Analytical Data
-
Gene name
ZYG11B
- Application
-
Alternative Names
Protein zyg-11 homolog B
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9C0D3
-
Expression Region
1-390 aa
-
AA Sequence
MEKTKPEILKLVVTGMRNHPMNLPVQLAASACVFNLTKQDLAAGMPVRLLADVTHLLLKAMEHFPNHQQLQKNCLLSLCSDRILQDVPFNRFEAAKLVMQWLCNHEDQNMQRMAVAIISILAAKLSTEQTAQLGTELFIVRQLLQIVKQKTNQNSVDTTLKFTLSALWNLTDESPTTCRHFIENQGLELFMRVLESFPTESSIQQKVLGLLNNIAEVQELHSELMWKDFIDHISSLLHSVEVEVSYFAAGIIAHLISRGEQAWTLSRSQRNSLLDDLHSAILKWPTPECEMVAYRSFNPFFPLLGCFTTPGVQLWAVWAMQHVCSKNPSRYCSMLIEEGGLQHLYNIKDHEHTDPHVQQIAVAILDSLEKHIVRHGRPPPCKKQPQARLN
-
Molecular Weight
68.64 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ZYG11B, a member of the ZYG11 protein family, has garnered significant attention in the field of molecular biology and biomedicine due to its crucial role in cell cycle regulation and tumorigenesis. Initially identified as a gene involved in the cell division process, ZYG11B is believed to participate in the degradation of key regulatory proteins, thereby influencing mitotic progression and maintaining genomic stability. Dysregulation of ZYG11B expression has been linked to various cancers, suggesting its potential as a biomarker for tumor initiation and progression. Recent studies have focused on the recombinant expression of ZYG11B to elucidate its structure-function relationships and provide insights into its mechanisms of action. This pursuit includes the production of ZYG11B recombinant proteins for functional assays, aiding in the identification of interaction partners and downstream signaling pathways. Understanding the implications of ZYG11B in cellular processes could unveil novel therapeutic strategies for cancer treatment. As researchers continue to explore the intricacies of this protein, the development of ZYG11B-targeted interventions holds promise for improving cancer outcomes and advancing precision medicine.
